A Randomized Controlled Trial of Intravenous Montelukast in Acute Asthma
The DOI matches its Crossref record.
Abstract
Many patients with acute asthma do not respond adequately to currently accepted therapy, including oxygen, beta-agonists, and corticosteroids. Leukotriene receptor antagonists such as montelukast have demonstrated efficacy in chronic asthma, but their efficacy in acute asthma is unknown. In this randomized, double-blind, parallel-group pilot study, adults with moderate to severe acute asthma received standard therapy plus either intravenous montelukast (7 or 14 mg) or matching placebo. A total of 201 patients were randomized, and 194 had complete data available for analysis. There was no difference in FEV1 response between the 7- and 14-mg montelukast groups. Montelukast improved FEV1 over the first 20 minutes after intravenous administration (mean percentage change from prerandomization baseline, 14.8% versus 3.6% for the pooled montelukast and placebo treatment groups, respectively; p = 0.007). This benefit was observed at 10 minutes and over 2 hours after intravenous therapy. Patients treated with montelukast tended to receive less beta-agonists and have fewer treatment failures than patients receiving placebo. The tolerability profile for montelukast was similar to that observed for placebo, and no unexpected adverse experiences were observed. We conclude that intravenous montelukast in addition to standard therapy causes rapid benefit and is well tolerated in adults with acute asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Peters-Golden, M., & Henderson, W. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071371 · Cited by 1,013
Kanaoka, Y., & Boyce, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1503 · Cited by 351
Camargo, C. A., Rachelefsky, G., & Schatz, M. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.p09st2 · Cited by 334
Self-citationMcFadden, E. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-902so · Cited by 317
Chauhan, B. F., & Ducharme, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002314.pub3 · Cited by 306
Rodrigo, G. J., Rodrigo, C., & Hall, J. B. (2004) · Chest · doi:10.1378/chest.125.3.1081 · Cited by 290
Mishra, V., Banga, J., & Silveyra, P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.011 · Cited by 271
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation
Boyce, J. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00512.x · Cited by 254
Asthma in Children and Adolescents: A Comprehensive Approach to Diagnosis and Management
Chang, C. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8261-3 · Cited by 51
Metadata
- Authors
- Camargo, C. A., Smithline, H. A., Malice, M.-P., Green, S. A., & Reiss, T. F.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-15
- Volume
- 167
- Issue
- 4
- Pages
- 528-533
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2008660872
- Cited by
- 194
- References
- 0
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.